Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981;75(4):391-5.
doi: 10.1007/BF00435860.

Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice

W H Riffee, R E Wilcox, C P Goldman, R V Smith

Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice

W H Riffee et al. Psychopharmacology (Berl). 1981.

Abstract

Based on previous work examining the effects of dextroamphetamine on pentylenetetrazol (PTZ)-induced clonic seizure threshold, the objective of the present study was to determine the effects of two other dopamine agonists, apomorphine (AP) and piribedil, on PTZ seizures. TD50 and LD50 values for CD-1 mice were determined initially for the two drugs. Subsequently, dose- and time-response analyses established that AP decreased PTZ seizure threshold 15 min after administraton, but increased the threshold at 60 min. Piribedil elevated the seizure threshold, but like AP, did not exhibit a clear dose-response relationship. Subsequent blocker studies with phentolamine, (-)sotalol, pimozide, and atropine suggested the possible neurotransmitter systems involved in the modulation of the PTZ-induced seizures by AP and piribedil. Pimozide blocked the changes in seizure threshold induced by both drugs. Atropine also decreased the AP-induced increase in threshold at 60 min. The pattern of inhibition of seizure threshold changes induced by the neurotransmitter blockers suggested that piribedil blocked seizures by means of indirect actions on several neurotransmitters.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. J Pharm Pharmacol. 1971 Dec;23(12):989-91 - PubMed
    1. J Pharm Pharmacol. 1972 Sep;24(9):696-701 - PubMed
    1. Arch Neurol. 1974 May;30(5):383-6 - PubMed
    1. Adv Neurol. 1975;9:307-26 - PubMed
    1. Adv Pharmacol Chemother. 1978;15:87-160 - PubMed

Publication types

LinkOut - more resources